Found: 454
Select item for more details and to access through your institution.
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 2, p. 192, doi. 10.1093/ejendo/lvae095
- By:
- Publication type:
- Article
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1602, doi. 10.1007/s00125-024-06160-1
- By:
- Publication type:
- Article
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1386, doi. 10.1007/s00125-024-06148-x
- By:
- Publication type:
- Article
The expanding incretin universe: from basic biology to clinical translation.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1765, doi. 10.1007/s00125-023-05906-7
- By:
- Publication type:
- Article
100 years of glucagon and 100 more.
- Published in:
- Diabetologia, 2023, v. 66, n. 8, p. 1378, doi. 10.1007/s00125-023-05947-y
- By:
- Publication type:
- Article
Long-term outcomes of dietary carbohydrate restriction for HbA<sub>1c</sub> reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter].
- Published in:
- 2022
- By:
- Publication type:
- Letter
Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats.
- Published in:
- Diabetologia, 2022, v. 65, n. 6, p. 1018, doi. 10.1007/s00125-022-05675-9
- By:
- Publication type:
- Article
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2022, v. 65, n. 3, p. 506, doi. 10.1007/s00125-021-05628-8
- By:
- Publication type:
- Article
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
- Published in:
- Diabetologia, 2021, v. 64, n. 11, p. 2425, doi. 10.1007/s00125-021-05547-8
- By:
- Publication type:
- Article
The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
- Published in:
- Diabetologia, 2021, v. 64, n. 3, p. 512, doi. 10.1007/s00125-020-05334-x
- By:
- Publication type:
- Article
Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
- Published in:
- Diabetologia, 2021, v. 64, n. 1, p. 142, doi. 10.1007/s00125-020-05288-0
- By:
- Publication type:
- Article
Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2410, doi. 10.1007/s00125-020-05249-7
- By:
- Publication type:
- Article
The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 7, p. 1285, doi. 10.1007/s00125-020-05158-9
- By:
- Publication type:
- Article
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.
- Published in:
- Diabetologia, 2020, v. 63, n. 5, p. 1043, doi. 10.1007/s00125-020-05093-9
- By:
- Publication type:
- Article
A carbohydrate-reduced high-protein diet improves HbA<sub>1c</sub> and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2019, v. 62, n. 11, p. 2066, doi. 10.1007/s00125-019-4956-4
- By:
- Publication type:
- Article
No direct effect of SGLT2 activity on glucagon secretion.
- Published in:
- Diabetologia, 2019, v. 62, n. 6, p. 1011, doi. 10.1007/s00125-019-4849-6
- By:
- Publication type:
- Article
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 665, doi. 10.1007/s00125-018-4810-0
- By:
- Publication type:
- Article
Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 582, doi. 10.1007/s00125-018-4807-8
- By:
- Publication type:
- Article
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 671, doi. 10.1007/s00125-017-4535-5
- By:
- Publication type:
- Article
GIP(3 -30)NH is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.
- Published in:
- Diabetologia, 2018, v. 61, n. 2, p. 413, doi. 10.1007/s00125-017-4447-4
- By:
- Publication type:
- Article
Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.
- Published in:
- Diabetologia, 2018, v. 61, n. 2, p. 284, doi. 10.1007/s00125-017-4450-9
- By:
- Publication type:
- Article
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 5, p. 623, doi. 10.1007/s00592-024-02239-8
- By:
- Publication type:
- Article
Canagliflozin or acarbose versus placebo to ameliorate post‐bariatric hypoglycaemia – The HypoBar I randomized clinical trial protocol.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 6, p. 1, doi. 10.1111/dme.15320
- By:
- Publication type:
- Article
Effects of prebiotics on postprandial GLP‐1, GLP‐2 and glucose regulation in patients with type 2 diabetes: A randomised, double‐blind, placebo‐controlled crossover trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14657
- By:
- Publication type:
- Article
Pancreatic polypeptide: A potential biomarker of glucose‐dependent insulinotropic polypeptide receptor activation in vivo.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 8, p. 1, doi. 10.1111/dme.14592
- By:
- Publication type:
- Article
Effects of a whey protein pre‐meal on bone turnover in participants with and without type 2 diabetes—A post hoc analysis of a randomised, controlled, crossover trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14471
- By:
- Publication type:
- Article
Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3213, doi. 10.1111/dom.15649
- By:
- Publication type:
- Article
Elucidating the glucose‐lowering effect of the bile acid sequestrant sevelamer.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1252, doi. 10.1111/dom.15421
- By:
- Publication type:
- Article
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52‐week randomized controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 201, doi. 10.1111/dom.15306
- By:
- Publication type:
- Article
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3079, doi. 10.1111/dom.15216
- By:
- Publication type:
- Article
Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1632, doi. 10.1111/dom.15017
- By:
- Publication type:
- Article
Exercise‐related hypoglycaemia induces QTc‐interval prolongation in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1186, doi. 10.1111/dom.14964
- By:
- Publication type:
- Article
A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 98, doi. 10.1111/dom.14851
- By:
- Publication type:
- Article
The effect of curcumin on hepatic fat content in individuals with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2192, doi. 10.1111/dom.14804
- By:
- Publication type:
- Article
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 2017, doi. 10.1111/dom.14789
- By:
- Publication type:
- Article
Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1882, doi. 10.1111/dom.14736
- By:
- Publication type:
- Article
Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1182, doi. 10.1111/dom.14673
- By:
- Publication type:
- Article
Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636
- By:
- Publication type:
- Article
Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 221, doi. 10.1111/dom.14568
- By:
- Publication type:
- Article
Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557
- By:
- Publication type:
- Article
Glucose‐dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double‐blind, placebo‐controlled, crossover clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 142, doi. 10.1111/dom.14545
- By:
- Publication type:
- Article
Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2009, doi. 10.1111/dom.14422
- By:
- Publication type:
- Article
Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1834, doi. 10.1111/dom.14402
- By:
- Publication type:
- Article
Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: A pilot dose‐ranging study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1311, doi. 10.1111/dom.14342
- By:
- Publication type:
- Article
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 530, doi. 10.1111/dom.14246
- By:
- Publication type:
- Article
Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 415, doi. 10.1111/dom.14233
- By:
- Publication type:
- Article
Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH<sub>2</sub> on GIP actions in humans.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 68, doi. 10.1111/dom.14186
- By:
- Publication type:
- Article
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2161, doi. 10.1111/dom.14146
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 10.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1, doi. 10.1111/dom.14188
- By:
- Publication type:
- Article
No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1837, doi. 10.1111/dom.14106
- By:
- Publication type:
- Article